APA (7th ed.) Citation

Casak, S. J., Lemery, S. J., Chung, J., Fuchs, C., Schrieber, S. J., Chow, E. C., . . . Pazdur, R. (2018). FDA's Approval of the First Biosimilar to Bevacizumab. Clinical cancer research, 24(18), 4365-4370. https://doi.org/10.1158/1078-0432.CCR-18-0566

Chicago Style (17th ed.) Citation

Casak, Sandra J., et al. "FDA's Approval of the First Biosimilar to Bevacizumab." Clinical Cancer Research 24, no. 18 (2018): 4365-4370. https://doi.org/10.1158/1078-0432.CCR-18-0566.

MLA (9th ed.) Citation

Casak, Sandra J., et al. "FDA's Approval of the First Biosimilar to Bevacizumab." Clinical Cancer Research, vol. 24, no. 18, 2018, pp. 4365-4370, https://doi.org/10.1158/1078-0432.CCR-18-0566.